Marianne Yood, DSc
Adjunct Research Associate Professor
Boston University School of Public Health

MPH, Boston University School of Public Health
BS, Boston University
DSc, Boston University School of Public Health

Dr. Ulcickas Yood has more than 25 years professional experience in epidemiologic research. Her research focuses on pharmacoepidemiology and drug safety as well as methodologic issues relating to exposure measurement and data quality in large administrative databases. She collaborates with the Cancer Research Network to study cancer treatment effectiveness and sequelae. Dr. Ulcickas Yood has served on various advisory boards related to pharmacoepidemiology and drug safety and is currently a member of the Editorial Board for Pharmacoepidemiology and Drug Safety. She has published over 75 articles in numerous journals and is currently a co-investigator on 6 NIH funded grants. In addition, Dr. Ulcickas Yood is principal epidemiologist at EpiSource, an organization that designs and implements pharmacoepidemiology studies.

Outcomes of Prostate Cancer Androgen Deprivation Therapy
04/02/2010 - 07/31/2014 (Subcontract PI)
Henry Ford Health System NIH NCI

Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort
04/01/2010 - 04/30/2014 (Subcontract PI)
Henry Ford Health System NIH NCI

Long-term Survivorship in Older Women with Early stage Breast Cancer
10/01/2009 - 07/31/2013 (Subcontract PI)
Boston Medical Center Corporation NIH NCI


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Persson R, Lee S, Yood MU, Wagner MR, Minton N, Niemcryk S, Lindholm A, Evans AM, Jick S. Incident depression in patients diagnosed with multiple sclerosis: a multi-database study. Eur J Neurol. 2020 08; 27(8):1556-1560.View Related Profiles. PMID: 32397001
  2. Persson R, Lee S, Yood MU, Wagner M, Minton N, Niemcryk S, Lindholm A, Evans A, Jick S. Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study. Mult Scler Relat Disord. 2020 Jan; 37:101423.View Related Profiles. PMID: 32172996
  3. Persson R, Lee S, Yood MU, Wagner M, Minton N, Niemcryk S, Lindholm A, Evans A, Jick S. Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries. J Neurol. 2019 May; 266(5):1095-1106.View Related Profiles. PMID: 30778708; PMCID: PMC6469671; DOI: 10.1007/s00415-019-09238-8;
  4. Bradley MC, Zhou Y, Freedman AN, Yood MU, Quesenbery CP, Haque R, Van Den Eeden SK, Cassidy-Bushrow AE, Aaronson D, Potosky AL. Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer. Cancer Causes Control. 2018 08; 29(8):785-791. PMID: 29959604; PMCID: PMC6660131; DOI: 10.1007/s10552-018-1050-z;
  5. Alford SH, Divine G, Chao C, Habel LA, Janakiraman N, Wang Y, Feigelson HS, Scholes D, Roblin D, Epstein MM, Engel L, Havstad S, Wells K, Yood MU, Fortuny J, Johnson CC. Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis. Cancer Causes Control. 2018 01; 29(1):143-156. PMID: 29192350; PMCID: PMC5864123; DOI: 10.1007/s10552-017-0987-7;
  6. Johnson CC, Jankowski M, Rolnick S, Yood MU, Alford SH. Influence of NSAID Use Among Colorectal Cancer Survivors on Cancer Outcomes. Am J Clin Oncol. 2017 Aug; 40(4):370-374. PMID: 25503426; PMCID: PMC4465051; DOI: 10.1097/COC.0000000000000164;
  7. Epstein MM, Divine G, Chao CR, Wells KE, Feigelson HS, Scholes D, Roblin D, Ulcickas Yood M, Engel LS, Taylor A, Fortuny J, Habel LA, Johnson CC. Statin use and risk of multiple myeloma: An analysis from the cancer research network. Int J Cancer. 2017 Aug 01; 141(3):480-487. PMID: 28425616; PMCID: PMC5508532; DOI: 10.1002/ijc.30745;
  8. Fu AZ, Tsai HT, Haque R, Yood MU, Cassidy-Bushrow AE, Van Den Eeden SK, Keating NL, Smith MR, Zhou Y, Aaronson DS, Potosky AL. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer. J Urol. 2017 06; 197(6):1448-1454. PMID: 28007467; PMCID: PMC5433922; DOI: 10.1016/j.juro.2016.12.086;
  9. Fu AZ, Tsai HT, Haque R, Ulcickas Yood M, Van Den Eeden SK, Cassidy-Bushrow AE, Zhou Y, Keating NL, Smith MR, Aaronson DS, Potosky AL. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer. World J Urol. 2016 Dec; 34(12):1611-1619. PMID: 27084777; PMCID: PMC5065786; DOI: 10.1007/s00345-016-1823-5;
  10. Ulcickas Yood M, Bortolini M, Casso D, Beck JG, Oliveria SA, Wells KE, Woodcroft KJ, Wang LI. Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system. Pharmacoepidemiol Drug Saf. 2015 Apr; 24(4):427-34. PMID: 25683797; DOI: 10.1002/pds.3757;
Showing 10 of 107 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 107 publications over 28 distinct years, with a maximum of 17 publications in 2007


2011 International Society for Pharmacoepidemiology: Fellow
1999 Bristol-Myers Squibb: Excellence Award
1995 Society for Epidemiologic Research: Student Workshop on Epidemiologic Methods
1995 American Society for Preventive Oncology: New Investigators Workshop
1990 US Public Health Service: Achievement Medal
1990 US Public Health Service: Citation
1986 Boston University: Dean's Citation for Student Leadership
Contact for Mentoring:

715 Albany St Talbot Building
Boston MA 02118
Google Map

Yood's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department